{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,30]],"date-time":"2026-08-30T18:48:22Z","timestamp":1788115702043,"version":"build-2803163510"},"reference-count":31,"publisher":"Public Library of Science (PLoS)","issue":"2","license":[{"start":{"date-parts":[[2021,2,24]],"date-time":"2021-02-24T00:00:00Z","timestamp":1614124800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001700","name":"the Ministry of Education, Culture, Sports, Science, and Technology in Japan","doi-asserted-by":"crossref","award":["S1101027"],"award-info":[{"award-number":["S1101027"]}],"id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:p>Bile acid has attracted attention as a signal transmission molecule in energy metabolism. Although a high-fat diet (HFD) or obesity is known to increase hepatic fat content and alter bile acid composition, the changes in bile acid composition due to HFD or obesity remain to be elucidated. We sought to examine the bile acid composition in high fat diet-induced non-alcoholic fatty liver disease (NAFLD) in obese diabetic rats. Eight-week-old male spontaneously diabetic Torii fatty (SDTF) rats or control rats were fed an HFD. Twelve weeks post the commencement of HFD, serum and hepatic bile acid compositions and serum GLP-1 levels, which is stimulated by the secondary bile acid deoxycholic acid (DCA), were measured. The correlation between the bile acid composition and serum GLP-1 levels was also examined. While serum and hepatic levels of cholic acid (CA), a primary bile acid, tended to decrease in HFD-fed control rats, they were significantly decreased in HFD-fed SDTF rats. Hepatic CYP8B1, which plays a role in CA synthesis, the mRNA levels were significantly decreased in HFD-fed control and SDTF rats. In contrast, while serum and hepatic DCA levels were not changed in HFD-fed control rats, they were decreased in HFD-fed SDTF rats. Hepatic DCA\/CA did not change in HFD-fed SDTF rats, but significantly increased in HFD-fed control rats. While serum GLP-1 levels were not changed in SDTF rats, they were significantly increased in HFD-fed control rats. Hepatic DCA\/CA tended to correlate with serum GLP-1 levels, which tended to negatively correlate with the hepatic triglyceride content in SDTF rats. These results indicate that relatively increased DCA might contribute to an increase in serum GLP-1 levels, which inhibits hepatic steatosis in NAFLD.<\/jats:p>","DOI":"10.1371\/journal.pone.0247303","type":"journal-article","created":{"date-parts":[[2021,2,24]],"date-time":"2021-02-24T18:33:00Z","timestamp":1614191580000},"page":"e0247303","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":22,"title":["Characteristics of bile acid composition in high fat diet-induced nonalcoholic fatty liver disease in obese diabetic rats"],"prefix":"10.1371","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2236-8095","authenticated-orcid":true,"given":"Yukiomi","family":"Nakade","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rena","family":"Kitano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazumasa","family":"Sakamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Kimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taeko","family":"Yamauchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tadahisa","family":"Inoue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuji","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomohiko","family":"Ohashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshio","family":"Sumida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiyoaki","family":"Ito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masashi","family":"Yoneda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2021,2,24]]},"reference":[{"issue":"1","key":"pone.0247303.ref001","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/hep.28431","article-title":"Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes","volume":"64","author":"ZM Younossi","year":"2016","journal-title":"Hepatology"},{"issue":"3","key":"pone.0247303.ref002","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1053\/j.gastro.2014.11.039","article-title":"Nonalcoholic steatohepatitis is the second leading etiology of liver disease among adults awaiting liver transplantation in the United States","volume":"148","author":"RJ Wong","year":"2015","journal-title":"Gastroenterology"},{"issue":"1","key":"pone.0247303.ref003","doi-asserted-by":"crossref","first-page":"1vii","DOI":"10.1016\/j.cld.2007.02.009","article-title":"Epidemiology and natural history of NAFLD and NASH","volume":"11","author":"JP Ong","year":"2007","journal-title":"Clin Liver Dis"},{"issue":"5","key":"pone.0247303.ref004","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1002\/hep.24001","article-title":"Evolution of inflammation in nonalcoholic fatty liver disease: the multiple parallel hits hypothesis","volume":"52","author":"H Tilg","year":"2010","journal-title":"Hepatology"},{"issue":"3","key":"pone.0247303.ref005","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1038\/s41575-019-0250-7","article-title":"Regulation of intestinal lipid metabolism: current concepts and relevance to disease","volume":"17","author":"CW Ko","year":"2020","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"4","key":"pone.0247303.ref006","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1124\/pr.113.008201","article-title":"Bile acid signaling in metabolic disease and drug therapy","volume":"66","author":"T Li","year":"2014","journal-title":"Pharmacol Rev"},{"issue":"1","key":"pone.0247303.ref007","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1159\/000324126","article-title":"The bile acid membrane receptor TGR5: a valuable metabolic target","volume":"29","author":"TW Pols","year":"2011","journal-title":"Dig Dis"},{"issue":"3","key":"pone.0247303.ref008","doi-asserted-by":"crossref","first-page":"584","DOI":"10.2337\/db07-1414","article-title":"Increasing GLP-1-induced beta-cell proliferation by silencing the negative regulators of signaling cAMP response element modulator-alpha and DUSP14","volume":"57","author":"S Klinger","year":"2008","journal-title":"Diabetes"},{"issue":"2","key":"pone.0247303.ref009","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1111\/j.1464-5491.2007.02333.x","article-title":"Liraglutide, a once-daily human GLP-1 analogue, improves pancreatic B-cell function and arginine-stimulated insulin secretion during hyperglycaemia in patients with Type 2 diabetes mellitus","volume":"25","author":"T Vilsboll","year":"2008","journal-title":"Diabet Med"},{"issue":"3","key":"pone.0247303.ref010","doi-asserted-by":"crossref","first-page":"R981","DOI":"10.1152\/ajpregu.00449.2007","article-title":"GLP-1 analogs: satiety without malaise?","volume":"293","author":"M Tang-Christensen","year":"2007","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"issue":"1\u20132","key":"pone.0247303.ref011","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.autneu.2006.06.007","article-title":"Glucagon like peptide-1 accelerates colonic transit via central CRF and peripheral vagal pathways in conscious rats","volume":"131","author":"Y Nakade","year":"2007","journal-title":"Auton Neurosci"},{"issue":"1","key":"pone.0247303.ref012","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1002\/hep.21006","article-title":"Exendin-4, a glucagon-like protein-1 (GLP-1) receptor agonist, reverses hepatic steatosis in ob\/ob mice","volume":"43","author":"X Ding","year":"2006","journal-title":"Hepatology"},{"issue":"8","key":"pone.0247303.ref013","doi-asserted-by":"crossref","first-page":"G762","DOI":"10.1152\/ajpgi.00476.2011","article-title":"Glucagon-like peptide-1 receptor agonism improves metabolic, biochemical, and histopathological indices of nonalcoholic steatohepatitis in mice","volume":"302","author":"JL Trevaskis","year":"2012","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"8","key":"pone.0247303.ref014","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1111\/j.1478-3231.2006.01315.x","article-title":"Incretin mimetics as a novel therapeutic option for hepatic steatosis","volume":"26","author":"ME Tushuizen","year":"2006","journal-title":"Liver Int"},{"issue":"10019","key":"pone.0247303.ref015","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/S0140-6736(15)00803-X","article-title":"Liraglutide safety and efficacy in patients with non-alcoholic steatohepatitis (LEAN): a multicentre, double-blind, randomised, placebo-controlled phase 2 study","volume":"387","author":"MJ Armstrong","year":"2016","journal-title":"Lancet"},{"issue":"6","key":"pone.0247303.ref016","doi-asserted-by":"crossref","first-page":"e0178436","DOI":"10.1371\/journal.pone.0178436","article-title":"Conophylline inhibits non-alcoholic steatohepatitis in mice","volume":"12","author":"Y Nakade","year":"2017","journal-title":"PLoS One"},{"issue":"4","key":"pone.0247303.ref017","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1007\/s00535-012-0651-7","article-title":"Angiotensin II type 1 receptor antagonist prevents hepatic carcinoma in rats with nonalcoholic steatohepatitis","volume":"48","author":"Y Tamaki","year":"2013","journal-title":"J Gastroenterol"},{"issue":"6","key":"pone.0247303.ref018","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1097\/MEG.0b013e3282f4710a","article-title":"Bile acid levels are increased in the liver of patients with steatohepatitis","volume":"20","author":"MM Aranha","year":"2008","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"2","key":"pone.0247303.ref019","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.taap.2013.01.022","article-title":"Decreased hepatotoxic bile acid composition and altered synthesis in progressive human nonalcoholic fatty liver disease","volume":"268","author":"AD Lake","year":"2013","journal-title":"Toxicol Appl Pharmacol"},{"issue":"12","key":"pone.0247303.ref020","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1002\/jhbp.678","article-title":"Decrease in major secondary bile acid, hyodeoxycholic acid, was the main alteration in hepatic bile acid compositions in a hypertensive nonalcoholic fatty liver disease model","volume":"26","author":"M Kodama","year":"2019","journal-title":"J Hepatobiliary Pancreat Sci"},{"issue":"5","key":"pone.0247303.ref021","doi-asserted-by":"crossref","first-page":"G537","DOI":"10.1152\/ajpgi.00311.2017","article-title":"Bile acid profiles within the enterohepatic circulation in a diabetic rat model after bariatric surgeries","volume":"314","author":"M Wei","year":"2018","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"7813","key":"pone.0247303.ref022","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1038\/s41586-020-2396-4","article-title":"A metabolic pathway for bile acid dehydroxylation by the gut microbiome","volume":"582","author":"M Funabashi","year":"2020","journal-title":"Nature"},{"issue":"6","key":"pone.0247303.ref023","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1016\/S0016-5085(96)70024-0","article-title":"7 alpha-dehydroxylating bacteria enhance deoxycholic acid input and cholesterol saturation of bile in patients with gallstones","volume":"111","author":"F Berr","year":"1996","journal-title":"Gastroenterology"},{"issue":"1\u20132","key":"pone.0247303.ref024","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/s11010-016-2774-2","article-title":"FGF21 ameliorates nonalcoholic fatty liver disease by inducing autophagy","volume":"420","author":"S Zhu","year":"2016","journal-title":"Mol Cell Biochem"},{"issue":"1","key":"pone.0247303.ref025","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1002\/oby.22344","article-title":"Pegbelfermin (BMS-986036), PEGylated FGF21, in Patients with Obesity and Type 2 Diabetes: Results from a Randomized Phase 2 Study","volume":"27","author":"ED Charles","year":"2019","journal-title":"Obesity (Silver Spring)"},{"issue":"3","key":"pone.0247303.ref026","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1002\/hep.23094","article-title":"Dysfunctional very-low-density lipoprotein synthesis and release is a key factor in nonalcoholic steatohepatitis pathogenesis","volume":"50","author":"K Fujita","year":"2009","journal-title":"Hepatology"},{"issue":"30","key":"pone.0247303.ref027","doi-asserted-by":"crossref","first-page":"9067","DOI":"10.3748\/wjg.v21.i30.9067","article-title":"Female spontaneously diabetic Torii fatty rats develop nonalcoholic steatohepatitis-like hepatic lesions","volume":"21","author":"Y Ishii","year":"2015","journal-title":"World J Gastroenterol"},{"issue":"4","key":"pone.0247303.ref028","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1002\/hep.30626","article-title":"Sex Differences in Nonalcoholic Fatty Liver Disease: State of the Art and Identification of Research Gaps","volume":"70","author":"A Lonardo","year":"2019","journal-title":"Hepatology"},{"issue":"12","key":"pone.0247303.ref029","doi-asserted-by":"crossref","first-page":"4184","DOI":"10.2337\/db13-0639","article-title":"Human insulin resistance is associated with increased plasma levels of 12alpha-hydroxylated bile acids","volume":"62","author":"RA Haeusler","year":"2013","journal-title":"Diabetes"},{"issue":"1","key":"pone.0247303.ref030","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.cmet.2011.11.010","article-title":"Impaired generation of 12-hydroxylated bile acids links hepatic insulin signaling with dyslipidemia","volume":"15","author":"RA Haeusler","year":"2012","journal-title":"Cell Metab"},{"issue":"5","key":"pone.0247303.ref031","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1515\/hsz-2018-0379","article-title":"Conversion of chenodeoxycholic acid to cholic acid by human CYP8B1","volume":"400","author":"L Fan","year":"2019","journal-title":"Biol Chem"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0247303","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,24]],"date-time":"2021-02-24T18:33:28Z","timestamp":1614191608000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0247303"}},"subtitle":[],"editor":[{"given":"Michael","family":"Bader","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2021,2,24]]},"references-count":31,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2021,2,24]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0247303","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,24]]}}}